Semax
A heavily-researched (largely Russian) nootropic/neuroprotective peptide, easy intranasal dosing.
Verdict, B · Viable
A substantial (if largely non-Western) evidence base and easy intranasal dosing; sourcing transparency is the main drag. Viable for the informed.
Overview
Semax is a synthetic ACTH-derived heptapeptide developed in Russia for stroke and cognitive disorders, and one of the most-studied cognitive peptides, a potent BDNF upregulator. Most clinical data originate outside Western registries; sourcing is moderate.
PepScore Breakdown, the four axes
Evidence
35% weightHow strong is the published human science?
Sourcing & COA
30% weightOur moatCan a buyer obtain an independently-verified, high-purity version?, our proprietary layer.
Safety & Risk
25% weightWhat is the real-world harm potential?
Practicality
10% weightHow easy is it to actually run a verified version?
Sources & Citations
Every claim cites a primary source. Citations are machine-audited against NCBI, see methodology.
Best-Sourced Vendor
Hydro Research Peptides
Vendor 80 · AStrong vendor grade (A) and the best verified supply right now for Semax, batch-matched independent COA freshness 78%.
Visit Hydro Research Peptides ↗Ranked by Source Match = Vendor Grade × batch-COA freshness. Affiliate status is never an input to any grade, and a paying vendor never outranks a non-paying one on a tie.How this works →
Want a clinical path?
Talk to a licensed provider about Semax and whether it's appropriate for your situation.
Talk to a Provider ↗Telehealth. Not medical advice, for educational purposes.
Get the PepEvolution Dispatch
Monthly COA findings, vendor changes, and new grades. Research/educational only, no spam.
Educational only, not medical advice. PepScore is an educational research grade, not a prescription or dosing recommendation. Some vendor links are affiliate links, this never affects grades. Consult a licensed healthcare provider before using any compound.